GlucoTrack (GCTK) Stock: Buy, Sell, or Hold?
GCTK - GlucoTrack, Inc. Common Stock
$1.19
-0.22 (-15.61%)
▼
5d:
-34.62%
30d:
-66.29%
90d:
+274.3%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When GCTK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: GCTK is down 34.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: GCTK is down 34.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: GCTK is currently trading at $1.19, which is considered slightly low relative to its 30-day fair value range of $1.10 to $3.27.
Technical Outlook: Technically, GCTK is in a uptrend. Immediate support is located at $1.15, while resistance sits at $3.25. Short-term momentum is weak, with the stock down 15.6% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GCTK is in a uptrend. Immediate support is located at $1.15, while resistance sits at $3.25. Short-term momentum is weak, with the stock down 15.6% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.10 -
$3.27
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-15.6%)
- WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.10 -
$3.27
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.15
Resistance Level
$3.25
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Share & Embed Analysis
Last updated: October 02, 2026 2:16 PM ET
Data refreshes hourly during market hours. Next update: 3:16 PM
Data refreshes hourly during market hours. Next update: 3:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GCTK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |
|
GKOS
Glaukos Corp |
STRONG BUY
15 analysts |
$199 | 72 BUY |
